Health Personalised Cancer Vaccine Passes First Safety Check in Ovarian Cancer TrialBy Benjamin ScottOctober 16, 20260 A phase 1 trial finds the personalised NeoVax vaccine, combined with nivolumab, feasible and acceptably safe for patients with platinum-sensitive ovarian cancer.
